Cell Therapy News Volume 23.02 | Jan 24 2022

    0
    29







    2022-01-24 | CTN 13.02


    Cell Therapy News by STEMCELL Technologies
    Vol. 13.02 – 24 January, 2022
    TOP STORY

    Magnesium Sensing via LFA-1 Regulates CD8+ T Cell Effector Function

    Low serum magnesium levels were associated with more rapid disease progression and shorter overall survival in CAR T cell and immune checkpoint antibody-treated patients.
    [Cell]

    AbstractGraphical AbstractPress Release

    Watch this lively panel discussion about genome editing & genome integrity at the Nature Research Round Table on hPSC Quality
    PUBLICATIONSRanked by the impact factor of the journal

    Long-Term Safety and Efficacy of Lentiviral Hematopoietic Stem/Progenitor Cell Gene Therapy for Wiskott–Aldrich Syndrome

    Scientists presented comprehensive, long-term follow-up results for eight patients with Wiskott–Aldrich syndrome having undergone a Phase I/II lentiviral vector-based gene therapy trial, with a focus on thrombocytopenia and autoimmunity.
    [Nature Medicine]

    Full ArticlePress Release

    Disrupting N-Glycan Expression on Tumor Cells Boosts Chimeric Antigen Receptor T Cell Efficacy against Solid Malignancies

    The authors showed that multiple carcinomas expressed extracellular N-glycans, whose abundance negatively correlated with CAR T cell killing.
    [Science Translational Medicine]

    Full Article

    The Synthetic Artificial Stem Cell (SASC): Shifting the Paradigm of Cell Therapy in Regenerative Engineering

    Researchers engineered a SASC system which mimicked the paracrine effect of the stem cell secretome and provided tailorability of the composition for targeted tissue regeneration.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Full Article

    CD19/BAFF-R Dual-Targeted CAR T Cells for the Treatment of Mixed Antigen-Negative Variants of Acute Lymphoblastic Leukemia

    To mitigate antigen escape and potentially improve the durability of remission, scientists developed a dual-targeting approach using an optimized, bispecific CAR construct that targets both CD19 and BAFF-R.
    [Leukemia]

    Abstract

    SUPT4H1-Edited Stem Cell Therapy Rescues Neuronal Dysfunction in a Mouse Model for Huntington’s Disease

    Transplanting SUPT4H1-edited Huntington’s disease (HD)-induced pluripotent stem cell-derived neural precursor cells (iPSC-NPCs) into the YAC128 HD transgenic mouse model improved motor function compared to unedited HD iPSC-NPCs.
    [NPJ Regenerative Medicine]

    Full Article

    Neurofilament Light Chain Serum Levels Correlate with the Severity of Neurotoxicity after CAR T Cell Treatment

    Researchers examined whether serum levels of neurofilament light chain, a marker of neuroaxonal injury, correlated with the severity of immune effector cell-associated neurotoxicity syndrome.
    [Blood Advances]

    Abstract

    Immune Translational Control by CPEB4 Regulates Intestinal Inflammation Resolution and Colorectal Cancer Development

    Scientists addressed the contribution of posttranscriptional regulation, by the RNA-binding protein CPEB4, to intestinal immune homeostasis and its role in inflammatory bowel diseases and colorectal cancer development.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Transplantation of 3D Adipose-Derived Stem Cell/Hepatocyte Spheroids Alleviates Chronic Hepatic Damage in a Rat Model of Thioacetamide-Induced Liver Cirrhosis

    Investigators reported a new approach that enables the formation of self-assembled 3D spheroids of adipose-derived stem cells and murine hepatocytes via reconstituted collagen fibers.
    [Scientific Reports]

    Full Article

    Fully Characterized Mature Human iPS- and NMP-Derived Motor Neurons Thrive without Neuroprotection in the Spinal Contusion Cavity

    Using a rat cervical hemicontusion model, the authors evaluated the survival and integration of human iPSC-derived spinal motor neurons and oligodendrocyte progenitor cells.
    [Frontiers in Cellular Neuroscience]

    Full Article
    Are Your Pluripotent Stem Cells What You Think They Are? Explore Now.
    REVIEWS

    NK Cells in the Brain: Implications for Brain Tumor Development and Therapy

    Natural killer (NK) cells lend themselves to off-the-shelf applications owing to their favorable safety profile and retained efficacy in an allogeneic setting.
    [Trends in Molecular Medicine]

    Abstract

    Development of the Immune System in the Human Embryo

    Fetal B-1 and B-2 B cells involved in innate and adaptive immune responses, respectively, arise in staggered waves of development from distinct progenitors.
    [Pediatric Research]

    Abstract

    The Current Landscape of Immunotherapy for Pediatric Brain Tumors

    The authors review recent advances and ongoing challenges in pediatric brain cancer immunotherapy, as well as considerations for efficient clinical translation of efficacious immunotherapies into pediatric settings.
    [Nature Cancer]

    Abstract
    INDUSTRY AND POLICY NEWS

    EdiGene Enters Strategic R&D Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and Platform Technologies

    EdiGene, Inc. announced a research and development collaboration with Haihe Laboratory of Cell Ecosystem to develop hematopoietic stem cell regenerative therapies and platform technology by combining resources and expertise from both sides.
    [EdiGene, Inc.]

    Press Release

    Japan University Uses iPS Cells to Treat Spinal Cord Injury for First Time

    Keio University in Tokyo said it has started the world’s first clinical test using induced pluripotent stem cells, or iPS cells, to treat patients with spinal cord injuries.
    [Kyodo News]

    Press Release
    FEATURED EVENT

    Lorne Cancer 2022

    February 10 – 12, 2022
    Lorne, Victoria, Australia

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – T Cell Therapeutics

    Kyverna Therapeutics, Inc. – Emeryville, California, United States

    Scientist – Epigenetics of Aging

    RWTH Aachen Medical School – Aachen, Germany

    Scientist – CART T Cell Cancer Immunotherapies

    Children’s Hospital of Philadelphia – Philadelphia, Pennsylvania, United States

    Project Manager – Therapeutic Development Branch

    National Institute of Health – Rockville, Maryland, United States

    Postdoctoral Research Associate – Tumor Stem Cells

    Queen Mary University of London – London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter